Cargando…
Dexmedetomidine as the primary anesthetic agent during cardiac surgery in an infant with a family history of malignant hyperthermia
Malignant hyperthermia (MH) is an acute hypermetabolic crisis triggered in susceptible patients by the administration of succinylcholine or a volatile anesthetic agent. When providing anesthetic care for MH-susceptible agents, a total intravenous anesthetic (TIVA) technique is frequently chosen. Whe...
Autores principales: | Naguib, Aymen, McKee, Chris, Phillips, Alistair, Tobias, Joseph D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227316/ https://www.ncbi.nlm.nih.gov/pubmed/22144934 http://dx.doi.org/10.4103/1658-354X.87276 |
Ejemplares similares
-
Effects of Theophylline on Anesthetized Malignant Hyperthermia-Susceptible Pigs
por: Fiege, Marko, et al.
Publicado: (2011) -
Malignant hyperthermia testing in probands with NO adverse anesthetic reaction
por: Sterling, Carly, et al.
Publicado: (2014) -
Intra-operative post-induction hyperthermia, possibly malignant hyperthermia: Anesthetic implications, challenges and management
por: Gulabani, Michell, et al.
Publicado: (2014) -
Remimazolam in a Pediatric Patient With a Suspected Family History of Malignant Hyperthermia
por: Petkus, Holly, et al.
Publicado: (2022) -
Dexmedetomidine as an Anesthetic Adjuvant in Cardiac Surgery: a
Cohort Study
por: Brandão, Paulo Gabriel Melo, et al.
Publicado: (2016)